Limited liability business entities include corporations, limited liability companies, limited liability partnerships, trusts, general partnerships and joint ventures in which one or more of the partners or parties are also limited liability business entities, and limited partnerships in which one or more of the general partners are also limited liability business entities. (7) Ecgonine, or any derivative, salt, isomer, or salt of isomer thereof. (iv) The area has a high rate of arrest, conviction, or incarceration related to the sale, possession, use, cultivation, manufacture, or transport of cannabis. Funds disbursed under this subsection may be used to expand administration of the healthy youth survey to student populations attending institutions of higher education in Washington; (c) Five thousand dollars to the University of Washington alcohol and drug abuse institute for the creation, maintenance, and timely updating of web-based public education materials providing medically and scientifically accurate information about the health and safety risks posed by marijuana use; (iv) Ninety-eight thousand dollars for fiscal year 2019 to the department of ecology for research on accreditation of marijuana product testing laboratories; (e) Four hundred sixty-five thousand dollars for fiscal year 2020, four hundred sixty-four thousand dollars for fiscal year 2021, two hundred seventy thousand dollars in fiscal year 2022, and two hundred seventy-six thousand dollars in fiscal year 2023 to the department of ecology for implementation of accreditation of marijuana product testing laboratories; (g) Eight hundred eight thousand dollars for each of fiscal years 2020 through 2023 to the department of health for the administration of the marijuana authorization database; (h) Six hundred thirty-five thousand dollars for fiscal year 2020, six hundred thirty-five thousand dollars for fiscal year 2021, six hundred twenty-one thousand dollars for fiscal year 2022, and six hundred twenty-seven thousand dollars for fiscal year 2023 to the department of agriculture for compliance-based laboratory analysis of pesticides in marijuana; (i) One million six hundred fifty thousand dollars for fiscal year 2022 and one million six hundred fifty thousand dollars for fiscal year 2023 to the department of commerce to fund the marijuana social equity technical assistance competitive grant program under RCW, (j) One hundred sixty-three thousand dollars for fiscal year 2022 and one hundred fifty-nine thousand dollars for fiscal year 2023 to the department of commerce to establish a roster of mentors as part of the cannabis social equity technical assistance grant program under Engrossed Substitute House Bill No. (4) If no person notifies the seizing law enforcement agency in writing of the person's claim of ownership or right to possession of items specified in subsection (1)(d), (g), or (h) of this section within forty-five days of the service of notice from the seizing agency in the case of personal property and ninety days in the case of real property, the item seized shall be deemed forfeited. (2) The board may not issue, transfer, or renew a cannabis retail license for any licensee in violation of the provisions of subsection (1) of this section. (2) The evaluation of the implementation of chapter 3, Laws of 2013 shall include, but not necessarily be limited to, consideration of the following factors: (a) Public health, to include but not be limited to: (i) Health costs associated with cannabis use; (ii) Health costs associated with criminal prohibition of cannabis, including lack of product safety or quality control regulations and the relegation of cannabis to the same illegal market as potentially more dangerous substances; and, (iii) The impact of increased investment in the research, evaluation, education, prevention and intervention programs, practices, and campaigns identified in RCW. (vv) "Ultimate user" means an individual who lawfully possesses a controlled substance for the individual's own use or for the use of a member of the individual's household or for administering to an animal owned by the individual or by a member of the individual's household. (Vegetable origin or chemical synthesis.) If a violation of this chapter is a violation of a federal law or the law of another state, a conviction or acquittal under federal law or the law of another state for the same act is a bar to prosecution in this state. '1-testosterone') (17-hydroxy-5-androst-1-en-3-one); (17) 4-dihydrotestosterone (17-hydroxy-androstan-3-one); (18) Drostanolone (17-hydroxy-2-methyl-5-androstan-3-one); (19) Ethylestrenol (17-ethyl-17-hydroxyestr-4-ene); (20) Fluoxymesterone (9-fluoro-17-methyl-11,17-dihydroxyandrost-4-en-3-one); (21) Formebolone (2-formyl-17-methyl-11,17-dihydroxyandrost-1,4-dien-3-one); (22) Furazabol (17-methyl-17-hydroxyandrostano[2,3-c]-furazan); (23) 13-ethyl-17-hydroxygon-4-en-3-one; (24) 4-hydroxytestosterone (4,17-dihydroxy-androst-4-en-3-one); (25) 4-hydroxy-19-nortestosterone (4,17-dihydroxy-estr-4-en-3-one); (26) Mestanolone (17-methyl-17-hydroxy-5-androstan-3-one); (27) Mesterolone (1 methyl-17-hydroxy-[5]-androstan-3-one); (28) Methandienone (17-methyl-17-hydroxyandrost-1,4-dien-3-one); (29) Methandriol (17-methyl-3,17-dihydroxyandrost-5-ene); (30) Methenolone (1-methyl-17-hydroxy-5-androst-1-en-3-one); (31) 17-methyl-3,17-dihydroxy-5a-androstane; (32) 17-methyl-3,17-dihydroxy-5a-androstane; (33) 17-methyl-3,17-dihydroxyandrost-4-ene; (34) 17-methyl-4-hydroxynandrolone (17-methyl-4-hydroxy-17-hydroxyestr-4-en-3-one); (35) Methyldienolone (17-methyl-17-hydroxyestra-4,9(10)-dien-3-one); (36) Methyltrienolone (17-methyl-17-hydroxyestra-4,9-11-trien-3-one); (37) Methyltestosterone (17-methyl-17-hydroxyandrost-4-en-3-one); (38) Mibolerone (7,17-dimethyl-17-hydroxyestr-4-en-3-one); (39) 17-methyl-1-dihydrotestosterone (17b-hydroxy-17-methyl-5-androst-1-en-3-one) (also known as '17--methyl-1-testosterone'); (40) Nandrolone (17-hydroxyestr-4-en-3-one); (41) 19-nor-4-androstenediol (3, 17-dihydroxyestr-4-ene); (42) 19-nor-4-androstenediol (3, 17-dihydroxyestr-4-ene); (43) 19-nor-5-androstenediol (3, 17-dihydroxyestr-5-ene); (44) 19-nor-5-androstenediol (3, 17-dihydroxyestr-5-ene); (45) 19-nor-4-androstenedione (estr-4-en-3,17-dione); (46) 19-nor-5-androstenedione (estr-5-en-3,17-dione); (47) Norbolethone (13, 17-diethyl-17-hydroxygon-4-en-3-one); (48) Norclostebol (4-chloro-17-hydroxyestr-4-en-3-one); (49) Norethandrolone (17-ethyl-17-hydroxyestr-4-en-3-one); (50) Normethandrolone (17-methyl-17-hydroxyestr-4-en-3-one); (51) Oxandrolone (17-methyl-17-hydroxy-2-oxa-[5]-androstan-3-one); (52) Oxymesterone (17-methyl-4,17-dihydroxyandrost-4-en-3-one); (53) Oxymetholone (17-methyl-2-hydroxymethylene-17-hydroxy-[5]-androstan-3-one); (54) Stanozolol (17-methyl-17-hydroxy-[5]-androst-2-eno[3,2-c]-pyrazole); (55) Stenbolone (17-hydroxy-2-methyl-[5]-androst-1-en-3-one); (56) Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone); (57) Testosterone (17-hydroxyandrost-4-en-3-one); (58) Tetrahydrogestrinone (13, 17-diethyl-17-hydroxygon-4,9,11-trien-3-one); (59) Trenbolone (17-hydroxyestr-4,9,11-trien-3-one); and. (a) The department shall register an applicant to manufacture or distribute controlled substances included in RCW. The highlights of the bill are: For those aged 21 and over, it allows possession of a set "personal use" amount of controlled substances (e.g., 40 grams of oxycodone, 1 gram of heroin). Sale or transfer of controlled substance to minor. Any person who violates this subsection is guilty of a crime and, upon conviction, shall be subject to the same term of imprisonment and/or fine as provided by this chapter for the . (e) The commission may authorize the possession and distribution of controlled substances by persons engaged in research. (3) After appropriation of the amounts identified in subsection (1) of this section, the legislature must annually appropriate such remaining amounts for the purposes listed in this subsection (3) as follows: (a) Fifty-two percent to the state basic health plan trust account to be administered by the Washington basic health plan administrator and used as provided under chapter. (4) The department, in conjunction with the board, must adopt rules on requirements for cannabis concentrates, useable cannabis, and cannabis-infused products that may be sold, or provided at no charge, to qualifying patients or designated providers at a retail outlet holding a medical cannabis endorsement. A cannabis product is provided free of charge if the sales price of the product purchased does not vary depending on the inclusion of the cannabis product provided free of charge. (3) To be issued an endorsement, a cannabis retailer must: (a) Not authorize the medical use of cannabis for qualifying patients at the retail outlet or permit health care professionals to authorize the medical use of cannabis for qualifying patients at the retail outlet; (b) Carry cannabis concentrates and cannabis-infused products identified by the department under subsection (4) of this section; (c) Not use labels or market cannabis concentrates, useable cannabis, or cannabis-infused products in a way that make them intentionally attractive to minors; (d) Demonstrate the ability to enter qualifying patients and designated providers in the medical cannabis authorization database established in RCW, (e) Keep copies of the qualifying patient's or designated provider's recognition card, or keep equivalent records as required by rule of the board or the department of revenue to document the validity of tax exempt sales; and. (c)(i) Up to six-tenths of one percent to the University of Washington and four-tenths of one percent to Washington State University for research on the short and long-term effects of marijuana use, to include but not be limited to formal and informal methods for estimating and measuring intoxication and impairment, and for the dissemination of such research. Cannabis retailers holding a medical cannabis endorsement may also provide these products at no charge to qualifying patients or designated providers. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof calculated as the free anhydrous base or alkaloid, in limited quantities as set forth in this subsection: (1) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium; (2) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (3) Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium; (4) Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (5) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (6) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; (7) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts; and. (e) Other substances. (v) Knowingly making a misrepresentation of fact to the board, an officer of the board, or an employee of the board related to conduct or an action that is, or alleged to be, any of the violations identified in (b)(i) through (iv) of this subsection (2); (c) May include cancellation of a license for cumulative violations only if a cannabis licensee commits at least four violations within a two-year period of time; (d) Must consider aggravating and mitigating circumstances and deviate from the prescribed penalties accordingly, and must authorize enforcement officers to do the same, provided that such penalty may not exceed the maximum escalating penalty prescribed by the board for that violation; and. (b) To use in the course of the manufacture, distribution, or dispensing of a controlled substance, or to use for the purpose of acquiring or obtaining a controlled substance, a registration number which is fictitious, revoked, suspended, or issued to another person; (c) To obtain or attempt to obtain a controlled substance, or procure or attempt to procure the administration of a controlled substance, (i) by fraud, deceit, misrepresentation, or subterfuge; or (ii) by forgery or alteration of a prescription or any written order; or (iii) by the concealment of material fact; or (iv) by the use of a false name or the giving of a false address; (d) To falsely assume the title of, or represent herself or himself to be, a manufacturer, wholesaler, pharmacist, physician, dentist, veterinarian, or other authorized person for the purpose of obtaining a controlled substance; (e) To make or utter any false or forged prescription or false or forged written order; (f) To affix any false or forged label to a package or receptacle containing controlled substances; (g) To furnish false or fraudulent material information in, or omit any material information from, any application, report, or other document required to be kept or filed under this chapter, or any record required to be kept by this chapter; (h) To possess a false or fraudulent prescription with intent to obtain a controlled substance; or. The notice of seizure in other cases may be served by any method authorized by law or court rule including but not limited to service by certified mail with return receipt requested. (t) "Dispense" means the interpretation of a prescription or order for a controlled substance and, pursuant to that prescription or order, the proper selection, measuring, compounding, labeling, or packaging necessary to prepare that prescription or order for delivery. 1443 (cannabis industry/equity) [chapter 169, Laws of 2021]; and. The extraction or separation of resin from cannabis, the processing of cannabis concentrates, and the processing of cannabis-infused products that include cannabis concentrates not purchased from a validly licensed cannabis retailer as an ingredient by any person other than a validly licensed cannabis processor each constitute manufacture of cannabis in violation of RCW, (2) Except for the use of butane, the board may not enforce this section until it has adopted the rules required by RCW, (1) It is an unfair or deceptive practice under RCW, (2) "Synthetic cannabinoid" includes any chemical compound identified in RCW, It is an unfair or deceptive practice under RCW. Inmates who stay out of trouble during incarceration may be eligible for parole in as little as one year. The possession, delivery, distribution, and sale of cannabis concentrates, useable cannabis, and cannabis-infused products in accordance with the provisions of this chapter and the rules adopted to implement and enforce it, by a validly licensed cannabis retailer, shall not be a criminal or civil offense under Washington state law. The following acts, when performed by a validly licensed cannabis producer or employee of a validly licensed cannabis producer in compliance with rules adopted by the board to implement and enforce this chapter, do not constitute criminal or civil offenses under Washington state law: (1) Production or possession of quantities of cannabis that do not exceed the maximum amounts established by the board under RCW. The legislature recognizes that it may be useful for a label or labeling to describe the intended role of a marijuana [cannabis] product that contains nutrients or other dietary ingredients, including herbs and other botanicals, to maintain a structure or function of the body, or characterize the documented mechanism by which the product acts to maintain such structure or function, provided that the claim is truthful and not misleading." (a) The commission shall place a substance in Schedule V upon finding that: (1) the substance has low potential for abuse relative to the controlled substances included in Schedule IV; (3) abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances included in Schedule IV. Incarceration. (ii) An outdoor advertisement at the site of an event to be held at an adult only facility that is placed at such site during the period the facility or enclosed area constitutes an adult only facility, but in no event more than fourteen days before the event, and that does not advertise any cannabis product other than by using a brand name to identify the event. (2) by a practitioner, or by the practitioner's authorized agent under the practitioner's supervision, for the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale. (k) No administrative sanction, or civil or criminal liability, authorized or created by this chapter may be imposed on a pharmacist for action taken in reliance on a reasonable belief that an order purporting to be a prescription was issued by a practitioner in the usual course of professional treatment or in authorized research. (g) At the end of each fiscal year, the treasurer must transfer any amounts in the dedicated marijuana account that are not appropriated pursuant to subsection (1) of this section and this subsection (2) into the general fund, except as provided in (g)(i) of this subsection (2). (ii) a substance for which there is an approved new drug application; (iii) a substance with respect to which an exemption is in effect for investigational use by a particular person under Section 505 of the federal food, drug, and cosmetic act, 21 U.S.C. (i) A statement that the social equity applicant qualifies as a social equity applicant and intends to own at least fifty-one percent of the proposed cannabis retail business or applicants representing at least fifty-one percent of the ownership of the proposed business qualify as social equity applicants; (ii) A description of how issuing a cannabis retail license to the social equity applicant will meet social equity goals; (iii) The social equity applicant's personal or family history with the criminal justice system including any offenses involving cannabis; (iv) The composition of the workforce the social equity applicant intends to hire; (v) Neighborhood characteristics of the location where the social equity applicant intends to operate, focusing especially on disproportionately impacted areas; and. (l) An individual practitioner may not dispense a substance included in Schedule II, III, or IV for that individual practitioner's personal use. (b) Employees of the department of health, who are so designated by the *board as enforcement officers are declared to be peace officers and shall be vested with police powers to enforce the drug laws of this state, including this chapter. (2) Any person who violates this section is guilty of a class C felony and upon conviction may be imprisoned for not more than two years, fined not more than two thousand dollars, or both. (viii) whether the substance is an immediate precursor of a controlled substance. The term includes opium, substances derived from opium (opium derivatives), and synthetic opiates. (b) "Retail sale" has the same meaning as in RCW. (a) "Board" means the state liquor and cannabis board. Whenever a controlled substance which is manufactured, distributed, dispensed, or acquired in violation of this chapter is seized at rental premises, the law enforcement agency shall make a reasonable attempt to discover the identity of the landlord and shall notify the landlord in writing, at the last address listed in the property tax records and at any other address known by the law enforcement agency, of the seizure and the location of the seizure. (7) When property is forfeited under this chapter the commission or seizing law enforcement agency may: (a) Retain it for official use or upon application by any law enforcement agency of this state release such property to such agency for the exclusive use of enforcing the provisions of this chapter; (b) Sell that which is not required to be destroyed by law and which is not harmful to the public; (c) Request the appropriate sheriff or director of public safety to take custody of the property and remove it for disposition in accordance with law; or. (4) It is unlawful for any person to place in any newspaper, magazine, handbill, or other publication any advertisement, knowing, or under circumstances where one reasonably should know, that the purpose of the advertisement, in whole or in part, is to promote the sale of objects designed or intended for use as drug paraphernalia. The voluntary compliance program must include recommendations on abating violations of this chapter and rules adopted under this chapter. "collect and remit," or 12 "collect and deliver," when used with reference to the department, 13 means that the department, either directly or through a collection 14 agreement authorized by RCW 9.94A . "Transit advertisements" means advertising on or within private or public vehicles and all advertisements placed at, on, or within any bus stop, taxi stand, transportation waiting area, train station, airport, or any similar transit-related location. The applicant must pay the cost of the review process directly to the scientific reviewer as designated by the board. Counties must receive 60 percent of the distribution based on each county's total proportional population. 25.2 Drug Abuse Sale, Purchase, Manufacture, . The term does not include a prescription or refill authorization verbally transmitted by telephone nor a facsimile manually signed by the practitioner. Any person who violates this subsection is guilty of a misdemeanor. The department of fish and wildlife may apply to the department of health for registration pursuant to the applicable provisions of this chapter to purchase, possess, and administer controlled substances for use in chemical capture programs. (3) When authorized by an administrative inspection warrant, an officer or employee designated by the commission may: (a) inspect and copy records required by this chapter to be kept; (b) inspect, within reasonable limits and in a reasonable manner, controlled premises and all pertinent equipment, finished and unfinished material, containers and labeling found therein, and, except as provided in subsection (5) of this section, all other things therein, including records, files, papers, processes, controls, and facilities bearing on violation of this chapter; and. State v. Blake is a 2021 Washington State Supreme Court decision that says the state's drug possession law is unconstitutional. (2) Subsections (1)(a) through (g) of this section must be adjusted annually based on the United States bureau of labor statistics' consumer price index for the Seattle area. One hundred twenty-five thousand dollars to the health care authority to design and administer the Washington state healthy youth survey, analyze the collected data, and produce reports, in collaboration with the office of the superintendent of public instruction, department of health, department of commerce, family policy council, and board. (b) After considering the factors enumerated in subsection (a) of this section, the commission shall make findings with respect thereto and adopt and cause to be published a rule controlling the substance upon finding the substance has a potential for abuse. The task force shall elect a chair from among its legislative members at the first meeting. Funds disbursed under this subsection may be used to expand administration of the healthy youth survey to student populations attending institutions of higher education in Washington; (b) Fifty thousand dollars to the health care authority for the purpose of contracting with the Washington state institute for public policy to conduct the cost-benefit evaluation and produce the reports described in RCW, (c) Five thousand dollars to the University of Washington alcohol and drug abuse institute for the creation, maintenance, and timely updating of web-based public education materials providing medically and scientifically accurate information about the health and safety risks posed by ((. (5) All signs, billboards, or other print advertising for cannabis businesses or cannabis products must contain text stating that cannabis products may be purchased or possessed only by persons twenty-one years of age or older. (cc) "Isomer" means an optical isomer, but in subsection (gg)(5) of this section, RCW. Rules may include scheduling of consultative services and prioritizing requests for the services while maintaining the enforcement requirements of this chapter. **(2) The "state liquor control board" was renamed the "state liquor and cannabis board" by. The location and content of the retail cannabis signs authorized under this subsection are subject to all other requirements and restrictions established in this section for indoor signs, outdoor signs, and other cannabis-related advertising methods. (iv) The total share of marijuana excise tax revenues distributed to counties and cities in (g)(i) of this subsection (2) may not exceed fifteen million dollars in fiscal years 2018, 2019, 2020, and 2021, and twenty million dollars per fiscal year thereafter. Sec. (3) It should not be surprising that mistakes have been made both by licensees and regulators, and that both have learned from these mistakes leading to a stronger, safer industry. (7) This section shall not apply to offenses defined and punishable under the provisions of RCW. 36 likes, 1 comments - Caldwell Police Department (@caldwellpolicedepartment) on Instagram: "On April 28 at 7:00 p.m., officers with the Caldwell Police Department . Possession of a controlled substance can be defined as a crime that occurs when a person is in actual or constructive possession of a drug or some other substance that is deemed to be illegal under federal and state laws. Characterizing flavors authorized under this section do not include any synthetic terpenes. (c) Depressants. (2) As the regulated marketplace has been developing, Washington residents with a strong entrepreneurial spirit have taken great financial and personal risk to become licensed and part of this nascent industry. (1) It is unlawful for any person to knowingly possess a controlled substance unless the substance was obtained directly from, or pursuant to, a valid prescription or order of a practitioner while acting in the course of his or her professional practice, or except as otherwise authorized by this chapter. No person may possess or attempt to possess a controlled substance or a controlled substance analog unless the person obtains the substance or the analog directly from, or pursuant to a valid prescription or order of, a practitioner who is acting in the course of his or her professional practice, or unless the person is otherwise authorized by this chapter to . (ss) "Secretary" means the secretary of health or the secretary's designee. (2) All revenues collected from the cannabis excise tax imposed under this section must be deposited each day in the dedicated cannabis account. (3) Any person who violates this section is guilty of a class C felony punishable under chapter. (f) Knowingly to keep or maintain any store, shop, warehouse, dwelling, building, vehicle, boat, aircraft, or other structure or place, which is resorted to by persons using controlled substances in violation of this chapter for the purpose of using these substances, or which is used for keeping or selling them in violation of this chapter. (2) Synthetic opiate and any derivative of synthetic opiate, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of the isomers, esters, ethers, and salts is possible within the specific chemical designation. A fee of seventy-five dollars will be charged for the processing of the change of stock ownership or corporate officers. (e) Must give substantial consideration to mitigating any penalty imposed on a licensee when there is employee misconduct that led to the violation and the licensee: (i) Established a compliance program designed to prevent the violation; (ii) Performed meaningful training with employees designed to prevent the violation; and. The suspension shall run concurrently with, and not less than, the term of the sentence for the violation. (1) Cannabis producers, processors, and retailers are prohibited from making sales of any cannabis or cannabis product, if the sale of the cannabis or cannabis product is conditioned upon the buyer's purchase of any service or noncannabis product. (ii) Three and one-half percent to counties, cities, and towns ratably on a per capita basis. Prescriptions shall be retained in conformity with the requirements of RCW. The recipient of the administrative violation notice may request a hearing under chapter, (a) Producers or processors from listing on their internet websites information related to retailers who sell or promote their products, including direct links to the retailers' internet websites; and, (b) Retailers from listing on their internet websites information related to producers or processors whose products those retailers sell or promote, including direct links to the producers or processors' websites; or.
Lucky Luciano Ring,
Dispatcher Appreciation Week 2021 Ideas,
Oversize Load Signs Harbor Freight,
Articles R